In vivo properties of attenuated rubella virus, "Cendehill" strain.
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects; D002335:Carnivora; D002490:Central Nervous System; D010856:Columbidae; D003348:Cortisone / Q000494:pharmacology; D046508:Culture Techniques; D004912:Erythrocytes / Q000276:immunology; D005260:Female; D005849:Gerbillinae; D006168:Guinea Pigs; D000882:Haplorhini; D006385:Hemagglutination Inhibition Tests; D007267:Injections; D007271:Injections, Intradermal; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D007668:Kidney; D051379:Mice; D009928:Organ Specificity; D011817:Rabbits; D051381:Rats; D012411:Rubella Vaccine / Q000008:administration & dosage; D012412:Rubella virus / Q000276:immunology* / Q000302:isolation & purification / Q000472:pathogenicity; D013045:Species Specificity; D014611:Vaccination; D014765:Viral Vaccines; D014774:Virulence; D014776:Virus Cultivation
D012411:Rubella Vaccine; D014765:Viral Vaccines; D003348:Cortisone